Research ID
hum0017-v1Release info
Research title
Exome sequencing of primary central nervous system lymphoma
Research overview
- Aims
- Primary central nervous system lymphoma (PCNSL) is a rare type lymphoma confined to the central nervous system. Effective therapies against PCNSL are severely limited. By conducting whole exome sequencing of PCNSL specimens, we aimed to reveal molecular mechanism underlying PCNSL carcinogenesis.
- Methods
- Genomic DNA was extracted from surgically resected PCNSL tissues and paired peripheral blood, and subjected to Exome analysis. RNA extracted from surgically resected PCNSL tissues was subjected to RNA-seq analysis.
- Participants/materials
- Forty-one cases diagnosed to have PCNSL
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000021 | NGS (Exome, RNA-seq) |
| Controlled-access (Type I) | 2020-09-28 |
Data provider
- Principal investigator
- Hiroyuki Mano
- Affiliation
- Division of Cellular Signaling, National Cancer Center Research Institute
Research projects
| Name | URL |
|---|---|
PCNSL Genomic Analysis |
Grants
| Name | Title | Project number |
|---|---|---|
Leading Advanced Projects for medical innovation, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED-LEAP) | Project for novel therapeutic targets in cancer | N/A |
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
Genomic characterization of primary central nervous system lymphoma |
Controlled access users
| Principal investigator | Affiliation | Country/Region | Research title | Period of data use | Dataset ID |
|---|---|---|---|---|---|
| Li WEI | National Key Laboratory of Birth Defects and Reproductive Health, Chongqing Institute of Population and Family Planning | China | Molecular understanding of Primary Central Nervous System Lymphoma (PCNSL) using single cell genomics | 2016-11-25 – 2022-11-02 | |
| Mosquera Orgueira Adrian | Lymphoproliferative Diseases Research Group, Insititute for Research in Health at Santiago de Compostela (IDIS) | Spain | An integrative analysis of Primary Central Nervous Systema Lymphoma (PCNSL) genomes | 2017-04-04 – 2023-08-21 | |
| Margaret Shipp | Division of Hematologic Neoplasia, Dana-Farber Cancer Institute | Massachusetts, United States | Development of a comprehensive approach to analyze genetic bases for immune evasion in Primary Central Nervous System Lymphoma | 2017-11-29 – 2023-08-22 | |
| Shigeru Chiba | Department of Hematology, University of Tsukuba | Japan | Indentification of neuroinflammatory cells supporting the development of primary central nervous system lymphoma | 2019-02-12 – 2024-05-01 | |
| Seishi Ogawa | Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University | Japan | Comprehensive analysis of genetic alterations in hematological malignancies. | 2020-01-09 – 2022-12-19 | |
| Jessica Okosun | Barts Cancer Institute, Queen Mary University of London | United Kingdom | Dissecting the molecular heterogeneity and evolution of central nervous system lymphomas | 2021-11-11 – 2026-03-02 | |
| Wei Hua | Neurosurgery, Huashan Hospital, Fudan University | China | Genomic and molecular characterization of primary central nervous system lymphoma | 2022-06-13 – 2023-10-11 | |
| Ryuta Saito | Neurosurgery, Nagoya University | Japan | Genetic analysis during the progression of brain tumors and its impact on tumor microenvironment formation | 2022-10-13 – 2027-03-31 | |
| Michiaki Hamada | Hamada Laboratory, Faculty of Science and Engineering, Waseda University | Japan | Construction of RNA-targeted Drug Discovery Database | 2023-01-05 – 2027-10-31 | |
| Shinsuke Iida | Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences | Japan | Whole Exome Sequencing Analysis of Diffuse Large B-Cell Lymphoma That Progressed to Central Nervous System | 2024-03-05 – 2025-04-14 | |
| Keisuke Kataoka | Division of Molecular Oncology, National Cancer Center Research Institute | Japan | A multicenter observational study on prognostic indices for primary central nervous system malignant lymphoma | 2025-09-02 – 2027-12-31 |